What is Bicara Therapeutics's R&D?

Bicara Therapeutics (BCAX) reported R&D of $33M in Q3 2025.

How has Bicara Therapeutics's R&D changed year-over-year?

Bicara Therapeutics's R&D increased by 107.5% year-over-year, from $15.9M to $33M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Bicara Therapeutics BCAX R&D

R&D at other companies

Eli LillyLLY

$3.51B+28.4%

AmgenAMGN

$1.72B+15.7%

ArriVent BioPharma, Inc.AVBP

$37.62M-38.6%

ImmunomeIMNM

$46.38M+25.8%

Arcus BiosciencesRCUS

$122M0.0%

Syndax PharmaceuticalsSNDX

$58.85M-4.5%

Segments

By segment

See full

Reportable Segment$47.5M+38.4%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.64B+81.4%

Enterprise value$1.32B+288%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Bicara Therapeutics’s 10-Q, filed November 10, 2025, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's R&D?: Bicara Therapeutics (BCAX) reported R&D of $33M in Q3 2025.
How has Bicara Therapeutics's R&D changed year-over-year?: Bicara Therapeutics's R&D increased by 107.5% year-over-year, from $15.9M to $33M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.